112 related articles for article (PubMed ID: 8282534)
21. Simultaneous in vivo time course and dose response evaluation for TCDD-induced impairment of the LPS-stimulated primary IgM response.
North CM; Crawford RB; Lu H; Kaminski NE
Toxicol Sci; 2009 Nov; 112(1):123-32. PubMed ID: 19675145
[TBL] [Abstract][Full Text] [Related]
22. Stochastic modeling of B lymphocyte terminal differentiation and its suppression by dioxin.
Zhang Q; Bhattacharya S; Kline DE; Crawford RB; Conolly RB; Thomas RS; Kaminski NE; Andersen ME
BMC Syst Biol; 2010 Apr; 4():40. PubMed ID: 20359356
[TBL] [Abstract][Full Text] [Related]
23. Elucidation of cellular targets responsible for tetrachlorodibenzo-p-dioxin (TCDD)-induced suppression of antibody responses: I. The role of the B lymphocyte.
Dooley RK; Holsapple MP
Immunopharmacology; 1988; 16(3):167-80. PubMed ID: 3267010
[TBL] [Abstract][Full Text] [Related]
24. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) inhibits the activation of antigen-specific T-cells in mice.
Lundberg K; Dencker L; Grönvik KO
Int J Immunopharmacol; 1992 May; 14(4):699-705. PubMed ID: 1521937
[TBL] [Abstract][Full Text] [Related]
25. The immunotoxic effects of dual exposure to PCP and TCDD.
Chen HM; Lee YH; Chen RJ; Chiu HW; Wang BJ; Wang YJ
Chem Biol Interact; 2013 Nov; 206(2):166-74. PubMed ID: 24051191
[TBL] [Abstract][Full Text] [Related]
26. Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on humoral immunity: I. Similarities to Staphylococcus aureus Cowan Strain I (SAC) in the in vitro T-dependent antibody response.
Morris DL; Jordan SD; Holsapple MP
Immunopharmacology; 1991; 21(3):159-69. PubMed ID: 1917438
[TBL] [Abstract][Full Text] [Related]
27. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) enhances antibody production and protein kinase activity in murine B cells.
Kramer CM; Johnson KW; Dooley RK; Holsapple MP
Biochem Biophys Res Commun; 1987 May; 145(1):25-33. PubMed ID: 3496088
[TBL] [Abstract][Full Text] [Related]
28. Putative link between transcriptional regulation of IgM expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin and the aryl hydrocarbon receptor/dioxin-responsive enhancer signaling pathway.
Sulentic CE; Holsapple MP; Kaminski NE
J Pharmacol Exp Ther; 2000 Nov; 295(2):705-16. PubMed ID: 11046109
[TBL] [Abstract][Full Text] [Related]
29. Sequestration of 2,3,7,8-tetrachlorodibenzo-p-dioxin by activated carbon eliminates bioavailability and the suppression of immune function in mice.
Boyd SA; Sallach JB; Zhang Y; Crawford R; Li H; Johnston CT; Teppen BJ; Kaminski NE
Environ Toxicol Chem; 2017 Oct; 36(10):2671-2678. PubMed ID: 28370362
[TBL] [Abstract][Full Text] [Related]
30. Relative sensitivities of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced Cyp1a-1 and Cyp1a-2 gene expression and immunotoxicity in female B6C3F1 mice.
Narasimhan TR; Craig A; Arellano L; Harper N; Howie L; Menache M; Birnbaum L; Safe S
Fundam Appl Toxicol; 1994 Nov; 23(4):598-607. PubMed ID: 7867912
[TBL] [Abstract][Full Text] [Related]
31. TCDD attenuates EAE through induction of FasL on B cells and inhibition of IgG production.
Kummari E; Rushing E; Nicaise A; McDonald A; Kaplan BLF
Toxicology; 2021 Jan; 448():152646. PubMed ID: 33253778
[TBL] [Abstract][Full Text] [Related]
32. LPS regulation of the immune response: separate mechanisms for murine B cell activation by lipid A (direct) and polysaccharide (macrophage-dependent) derived from Bacteroides LPS.
Williamson SI; Wannemuehler MJ; Jirillo E; Pritchard DG; Michalek SM; McGhee JR
J Immunol; 1984 Nov; 133(5):2294-300. PubMed ID: 6332842
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of TC-1 cytokine production, effector cytotoxic T lymphocyte development and alloantibody production by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Kerkvliet NI; Baecher-Steppan L; Shepherd DM; Oughton JA; Vorderstrasse BA; DeKrey GK
J Immunol; 1996 Sep; 157(6):2310-9. PubMed ID: 8805628
[TBL] [Abstract][Full Text] [Related]
34. Induction of apoptosis by 2,3,7,8-tetrachlorodibenzo-p-dioxin following endotoxin exposure.
Patterson RM; Stachlewitz R; Germolec D
Toxicol Appl Pharmacol; 2003 Jul; 190(2):120-34. PubMed ID: 12878042
[TBL] [Abstract][Full Text] [Related]
35. Suppression of B cell differentiation by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Tucker AN; Vore SJ; Luster MI
Mol Pharmacol; 1986 Apr; 29(4):372-7. PubMed ID: 3486342
[TBL] [Abstract][Full Text] [Related]
36. 2,3,7,8-Tetrachlorodibenzo-p-dioxin induces suppressor of cytokine signaling 2 in murine B cells.
Boverhof DR; Tam E; Harney AS; Crawford RB; Kaminski NE; Zacharewski TR
Mol Pharmacol; 2004 Dec; 66(6):1662-70. PubMed ID: 15371557
[TBL] [Abstract][Full Text] [Related]
37. Effects of a single dose of 2,3,7,8-tetrachlorodibenzo-p-dioxin, given at post-puberty, in senescent mice.
Esser C; Steinwachs S; Herder C; Majora M; Lai ZW
Toxicol Lett; 2005 Jun; 157(2):89-98. PubMed ID: 15836996
[TBL] [Abstract][Full Text] [Related]
38. Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) treatment in vivo on thymocyte functions in mice after activation in vitro.
Lundberg K; Dencker L; Grönvik KO
Int J Immunopharmacol; 1990; 12(4):459-66. PubMed ID: 1975249
[TBL] [Abstract][Full Text] [Related]
39. Trypsin does not reconstitute responsiveness to lipopolysaccharide in the strain C3H/HeJ, but is a B-cell mitogen-like lipopolysaccharide, stimulating a different subpopulation.
Cardell S; Möller G
Scand J Immunol; 1989 Feb; 29(2):143-9. PubMed ID: 2784220
[TBL] [Abstract][Full Text] [Related]
40. Influence of the Ah locus on the humoral immunotoxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin: evidence for Ah-receptor-dependent and Ah-receptor-independent mechanisms of immunosuppression.
Kerkvliet NI; Steppan LB; Brauner JA; Deyo JA; Henderson MC; Tomar RS; Buhler DR
Toxicol Appl Pharmacol; 1990 Aug; 105(1):26-36. PubMed ID: 2168100
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
